Veozah Prior Authorization Criteria - Medicare Part D
Medicare Utilization Management Policy
Version Date: January 1, 2025
Prior Authorization Criteria for Approval
Veozah will be approved when ALL the following are met:
-
The patient has an FDA labeled indication for the requested medication
AND -
The patient does NOT have any FDA labeled contraindications to the requested medication
AND -
ONE of the following:
-
The requested quantity (dose) does NOT exceed the program quantity limit
OR -
ALL of the following:
- The requested quantity (dose) is greater than the program quantity limit
AND - The requested quantity (dose) cannot be achieved with a lower quantity of a higher strength that does not exceed the program quantity limit
AND - The prescriber has provided information in support of therapy with a higher dose for the requested indication
- The requested quantity (dose) is greater than the program quantity limit
-
Length of Approval: 12 months